Peritoneal sclerosis occurred in two patients treated by continuous ambulatory peritoneal dialysis (CAPD) using only lactate-buffered dialysate. Both patients had recurrent peritonitis and the second patient had multiple, minor abdominal operations. Patients receiving lactate-buffered CAPD are not immune from peritoneal sclerosis. Recurrent peritonitis and repeated abdominal surgery might be important causative factors.
ThomsonN.M., AtkinsR.C., HookeD., MaydomB., ScottD.F.Long term clinical experience in Australia. In: AtkinsR.C., ThomsonN.M., FarrellP.C., eds. Peritoneal dialysis.New York, New York: Churchill Livingstone1981, 93–103.
8.
ParsooI., HaffejeeA.A., NaickerS., PloumidesA., SeedatY.K.Intestinal obstruction due to adhesions complicating CAPD.Peritoneal Dial Bull1983; 3: 43.
9.
SlingeneyerA., MionC., MouradG., CanaudB., FallerB., BeraudJ.J.Progressive sclerosing peritonitis: A late and severe complication of maintenance peritoneal dialysis.Trans Am Soc Intern Organs1983; 29: 633–8.
HauglustaineD., van MeerbeekJ., MonballyuJ., GoddeerisP., LauwerijnsJ., MichielsenP.Sclerosing peritonitis with mural bowel fibrosis in a patient on long-term CAPD.Clin Nephrol1984; 22: 158–62.
13.
ManosJ., PostlethwaiteR.J., MallickN.P., GokalR.Sclerosing encapsulating peritonitis and other complications of CAPD peritonitis. In: MaherJ.F., WinchesterJ.F., eds. Frontiers in peritoneal dialysis.New York, New York: Field, Rich and Associates, Inc., 1986; 634–7.
14.
McWinnieD.L., BradleyJ.A., BramwellS.P.Sclerosing peritonitis - A further complications of CAPD. In: MaherJ.F., WinchesterJ.F., eds. Frontiers in peritoneal dialysis.New York, New York: Field, Rich and Associates, Inc., 1986; 638–42.
15.
JunorB.J.R., BriggsJ.D., ForwellM.A., DobbieJ.W., HendersonI.Sclerosing peritonitis - The contribution of chlorhexidine in alcohol.Peritoneal Dial Bull1985; 5: 101–4.
16.
GandhiV.C., KamadanaM.R., IngT.S.Aseptic peritonitis in patients on maintenance peritoneal dialysis.Nephron1979; 24: 257–9.
17.
WilliamsP., KhannaR., OreopoulosD.G.Treatment of peritonitis in patients on CAPD: No longer a controversy.Dial Transplantation1981; 10: 272.
18.
AshS.R., StruewingJ.D.Clinical trials of the column disc peritoneal catheter (Lifecath™).Peritoneal Dial Bull1983; 3: 77–80.
19.
VergerC., BrunschvicgO., Le CarpentierY., LavergneA., VantelonJ.Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis.Proc Eur Dial Transplant Assoc1981; 18: 199–205.
20.
SorkinM.I., LugerA.M., ProwantB., KennedyJ., MooreH., NolphK.D.Histologic and functional characteristics of the peritoneal membrane of a diabetic patient after 34 months of CAPD.Peritoneal Dial Bull1982; 2: 24–27.
21.
RubinJ., NolphK.D., ArfaniaD., BrownP., ProwantB.Follow-up of peritoneal clearances in patients undergoing continuous ambulatory peritoneal dialysis.Kidney Int1979; 16: 619–23.
22.
ShaldonS., KochK.M., QuellhorstE., DinarelloC.A.Hazards of CAPD: Interleukin-1 production. In: Frontiers in peritoneal dialysis.MaherJ.F., WinchesterJ.F. eds. Field, Rich and Associates, Inc, New York, New York, 1986, p. 630–3.
